Esperion Therapeutics ESPR Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's preferred stock, shares authorized?
- Esperion Therapeutics (ESPR) reported preferred stock, shares authorized of $5M in Q1 2026.
- How has Esperion Therapeutics's preferred stock, shares authorized changed year-over-year?
- Esperion Therapeutics's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
- What is the long-term trend for Esperion Therapeutics's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Esperion Therapeutics's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.